219 related articles for article (PubMed ID: 27228557)
1. Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.
Takahashi H; Sakakura K; Mito I; Ida S; Chikamatsu K
Cancer Sci; 2016 Aug; 107(8):1065-71. PubMed ID: 27228557
[TBL] [Abstract][Full Text] [Related]
2. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
3. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
4. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
Weed DT; Vella JL; Reis IM; De la Fuente AC; Gomez C; Sargi Z; Nazarian R; Califano J; Borrello I; Serafini P
Clin Cancer Res; 2015 Jan; 21(1):39-48. PubMed ID: 25320361
[TBL] [Abstract][Full Text] [Related]
5. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
6. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
7. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
Younis RH; Han KL; Webb TJ
J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
[TBL] [Abstract][Full Text] [Related]
8. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.
Turksma AW; Bontkes HJ; van den Heuvel H; de Gruijl TD; von Blomberg BM; Braakhuis BJ; Leemans CR; Bloemena E; Meijer CJ; Hooijberg E
Oral Dis; 2013 Sep; 19(6):577-84. PubMed ID: 23176702
[TBL] [Abstract][Full Text] [Related]
9. Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.
Li SH; Lin WC; Huang TL; Chen CH; Chiu TJ; Fang FM; Huang WT; Hsu CM; Luo SD; Lai CC; Su YY; Chuang HC; Chien CY
Head Neck; 2016 Apr; 38 Suppl 1():E844-52. PubMed ID: 25917382
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
[TBL] [Abstract][Full Text] [Related]
11. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.
Chen L; Huang CF; Li YC; Deng WW; Mao L; Wu L; Zhang WF; Zhang L; Sun ZJ
Cell Mol Life Sci; 2018 Jun; 75(11):2045-2058. PubMed ID: 29184980
[TBL] [Abstract][Full Text] [Related]
12. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ
J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
[TBL] [Abstract][Full Text] [Related]
13. Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck.
Sakakura K; Chikamatsu K; Takahashi K; Whiteside TL; Furuya N
Cancer Immunol Immunother; 2006 Feb; 55(2):151-9. PubMed ID: 15889251
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma.
Yang WC; Chen CH; Tang JY; Wu CF; Liu YC; Sun Y; Lin SF
Anticancer Res; 2014 Jul; 34(7):3765-73. PubMed ID: 24982400
[TBL] [Abstract][Full Text] [Related]
15. CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression.
Sun W; Li WJ; Wu CY; Zhong H; Wen WP
J Exp Clin Cancer Res; 2014 Apr; 33(1):35. PubMed ID: 24761979
[TBL] [Abstract][Full Text] [Related]
16. Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.
Kuss I; Donnenberg AD; Gooding W; Whiteside TL
Br J Cancer; 2003 Jan; 88(2):223-30. PubMed ID: 12610507
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy.
Schuler PJ; Börger V; Bölke E; Habermehl D; Matuschek C; Wild CA; Greve J; Bas M; Schilling B; Bergmann C; Trellakis S; Budach W; Gauler T; Brandau S; Lang S; Whiteside TL; Sorg RV; Hoffmann TK
Eur J Med Res; 2011 Feb; 16(2):57-62. PubMed ID: 21463982
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Toyoda M; Takahashi K; Yamamoto T; Masuyama K
Cancer Sci; 2012 Jun; 103(6):976-83. PubMed ID: 22360618
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Schultz JD; Bran G; Anders C; Sadick H; Faber A; Hörmann K; Sauter A
Oncol Rep; 2010 Nov; 24(5):1213-6. PubMed ID: 20878112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
